IGF2BP3 and cancer: The research of Oh et al points to the fact that the upregulation of m6A-reading proteins, particularly IGF2BP3, is connected to adverse survival, increased proliferation, and epithelial-mesenchymal transition (EMT) activation across diverse cancers, including gastric and colorectal carcinomas 18.